Quest Diagnostics Incorporated (DGX)
NYSE: DGX · Real-Time Price · USD
195.60
+0.34 (0.17%)
At close: Mar 23, 2026, 4:00 PM EDT
195.40
-0.20 (-0.10%)
Pre-market: Mar 24, 2026, 8:36 AM EDT
Quest Diagnostics Stock Forecast
Stock Price Forecast
The 13 analysts that cover Quest Diagnostics stock have a consensus rating of "Buy" and an average price target of $208.62, which forecasts a 6.66% increase in the stock price over the next year. The lowest target is $178 and the highest is $235.
Price Target: $208.62 (+6.66%)
Analyst Consensus: Buy
* Price targets were last updated on Feb 12, 2026.
Analyst Ratings
The average analyst rating for Quest Diagnostics stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Oct '25 | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 2 | 2 |
| Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Hold | 9 | 9 | 9 | 9 | 8 | 8 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 15 | 15 | 15 | 15 | 13 | 13 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Mizuho | Mizuho | Buy Maintains $210 → $235 | Buy | Maintains | $210 → $235 | +20.14% | Feb 12, 2026 |
| Truist Securities | Truist Securities | Hold Maintains $205 → $220 | Hold | Maintains | $205 → $220 | +12.47% | Feb 11, 2026 |
| UBS | UBS | Hold Maintains $190 → $210 | Hold | Maintains | $190 → $210 | +7.36% | Feb 11, 2026 |
| Evercore ISI Group | Evercore ISI Group | Hold Maintains $190 → $220 | Hold | Maintains | $190 → $220 | +12.47% | Feb 11, 2026 |
| Barclays | Barclays | Buy Maintains $210 → $225 | Buy | Maintains | $210 → $225 | +15.03% | Feb 11, 2026 |
Financial Forecast
Revenue This Year
11.87B
from 11.04B
Increased by 7.53%
Revenue Next Year
12.31B
from 11.87B
Increased by 3.77%
EPS This Year
10.74
from 8.75
Increased by 22.75%
EPS Next Year
11.55
from 10.74
Increased by 7.53%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|
| High | 12.4B | 13.1B | ||
| Avg | 11.9B | 12.3B | ||
| Low | 11.3B | 11.4B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|
| High | 12.4% | 10.2% | ||
| Avg | 7.5% | 3.8% | ||
| Low | 2.6% | -4.3% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|
| High | 11.41 | 12.43 | ||
| Avg | 10.74 | 11.55 | ||
| Low | 10.29 | 10.87 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|
| High | 30.4% | 15.8% | ||
| Avg | 22.7% | 7.5% | ||
| Low | 17.6% | 1.2% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.